MERIDIAN, IDAHO - 4/26/05 - MWI Veterinary Supply, a nationwide distributor of animal health products, is poised for its initial public offering after filing a registration statement with the U.S. Securities and Exchange Commission.
MERIDIAN, IDAHO - 4/26/05 - MWI Veterinary Supply, a nationwide distributor of animal health products, is poised for its initial public offering after filing a registration statement with the U.S. Securities and Exchange Commission.
Banc of America Securities LLC is serving as the sole bookrunner for the offering, and William Blair & Co. LLC and Jaffray & Co. are acting as co-managers.
MWI distributes more than 10,000 products from more than 350 vendors to more than 14,000 veterinary practices. About two-thirds of MWI's total revenues are generated from sales of companion animal products and one-third from production animal products. The comapany's revenues were $394.3 million for fiscal year 2004, and its operating income was $12.6 million. For the three months ending Dec. 31, 2004, total revenues were $109 million, and operating income was $5.3 million.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More